Somayeh Ebrahimibarough | Cell Biology | Best Researcher Award

Posted on by sciencefather

Prof. Somayeh Ebrahimibarough | Cell Biology | Best Researcher Award 

Associate Professor, at Tehran University of Medical Sciences, Iran.

Dr. Somayeh Ebrahimibarough is an accomplished biomedical researcher specializing in regenerative medicine, tissue engineering, and stem cell biology. She holds a Ph.D. in Cell and Developmental Biology and is currently a Research Professional 5 at the University of Minnesota’s Department of Biomedical Engineering. Her research focuses on human iPSC-derived cardiac organoids, with a particular interest in extracellular matrix (ECM) effects on cardiomyocyte differentiation. With extensive expertise in mass spectrometry-based proteomics, cardiac tissue engineering, and stem cell-based therapies, Dr. Ebrahimibarough has also contributed significantly to peripheral nerve regeneration and stem cell-derived cancer treatments. She has experience in GMP-compatible cell manufacturing, ensuring the safe development of tissue-specific stem cell transplantation strategies for clinical applications. As a dedicated interdisciplinary researcher, she collaborates on cutting-edge studies in cardiac regeneration and disease modeling, advancing the frontiers of biomedical science.

Professional Profile

Google Scholar

🎓 Education

Dr. Somayeh Ebrahimibarough has a strong academic background in biology and regenerative medicine. She earned her Ph.D. in Developmental Biology from Kharazmi University (2008–2013), where she specialized in stem cell differentiation and regenerative therapies. Before that, she completed her M.S. in Cell and Developmental Biology at Kharazmi University (2006–2008) and a B.S. in Biology from Mohaghegh Ardabili University (2002–2005). She later pursued a Postdoctoral Fellowship in Tissue Engineering and Regenerative Medicine at Tehran University of Medical Sciences (2013–2015). Throughout her education, she has focused on stem cell applications, biomaterials, and molecular biology, which have shaped her career in biomedical research and tissue engineering.

💼 Experience

Dr. Ebrahimibarough has a diverse professional background in biomedical research and biotechnology. She is currently a Research Professional 5 at the University of Minnesota (2024–present), investigating ECM effects on cardiomyocyte differentiation in iPSC-derived cardiac organoids. Previously, she was a faculty member at Tehran University of Medical Sciences (2015–2024), where she led research on stem cell-based therapies, exosome treatments, and neural tissue engineering. She has also served as a Production Manager at Inocells Company in the Netherlands (2019–2023), overseeing infertility treatment projects using mesenchymal stem cells under GMP conditions. Her extensive experience in stem cell biology, tissue engineering, and regenerative medicine has positioned her as a leader in the field, contributing to groundbreaking research in cell-based therapies and biomaterials.

🔬 Research Interests

Dr. Ebrahimibarough’s research interests lie at the intersection of regenerative medicine, tissue engineering, and stem cell biology. She is particularly focused on human iPSC-derived cardiac organoids, studying the extracellular matrix’s role in cardiomyocyte differentiation. Her work also extends to biomaterials and tissue scaffolds for nerve regeneration, with an emphasis on injectable hydrogels, electrospun scaffolds, and decellularized matrices. Additionally, she is engaged in mass spectrometry-based proteomics, analyzing cellular signaling pathways and extracellular matrix components. Dr. Ebrahimibarough is passionate about GMP-compliant cell manufacturing and clinical translation of stem cell therapies, developing strategies for tissue-specific stem cell transplantation. Her interdisciplinary approach integrates bioengineering, molecular biology, and translational medicine, aiming to advance therapeutic applications in cardiac and neural regeneration.

🏆 Awards & Recognitions

Dr. Ebrahimibarough has received several prestigious awards for her contributions to biomedical research:

  • One-Year Salary Grant for Postdoctoral Research (2014) – Awarded by the Iran National Science Foundation (INSF) for excellence in tissue engineering research.
  • Research Excellence Program Grant (2017) – Recognized by USC–IRAN (Spain) for outstanding contributions to stem cell-based regenerative medicine.
  • Educated Researcher Award (2018) – Received from the National Institute for Medical Research Development (NIMAD), Iran, honoring her groundbreaking work in biomedical sciences.

Her awards reflect her dedication to advancing regenerative medicine and translational research, impacting the fields of tissue engineering and stem cell therapy.

📚 Top Noted Publications

Dr. Ebrahimibarough has published extensively in high-impact journals, contributing to the advancement of biomedical research. Here are some of her key publications:

  • Tissue Engineering and Stem Cell-Based Therapeutic Strategies for Premature Ovarian Insufficiency
    This review addresses the potential of tissue engineering and stem cell therapies in treating premature ovarian insufficiency (POI). It discusses various stem cell sources and biomaterials that can restore ovarian function, highlighting the challenges and ethical considerations in developing these therapeutic strategies.

    PubMed

  • Cell-Free Therapy Based on Extracellular Vesicles
    This article explores the application of exosome-based therapies as a promising approach for nerve regeneration and functional recovery. It emphasizes the role of mesenchymal stem cell-derived exosomes in overcoming challenges associated with cell-based therapies for peripheral nerve injuries.

    PubMed Central

  • Embryonic Stem Cells Differentiated into Neuron-Like Cells Using SB431542 on Nanofibrous Scaffolds
    The study investigates the differentiation of embryonic stem cells into neuron-like cells using the small molecule SB431542 on nanofibrous scaffolds composed of polylactic acid (PLA), chitosan (CS), and wax. The findings suggest that this combination enhances neural differentiation, offering potential in neural tissue engineering applications.

    experts.umn.edu

  • Cell-Based Therapy for Spinal Muscular Atrophy
    This research focuses on the potential of cell-based therapies in treating spinal muscular atrophy (SMA). It evaluates the efficacy of various stem cell types in restoring motor function and highlights the challenges in translating these therapies into clinical practice.

    experts.umn.edu

  • Stimulation of Osteogenic Differentiation of Induced Pluripotent Stem Cells Using Bioactive Glasses
    The study examines the effect of bioactive glasses on the osteogenic differentiation of induced pluripotent stem cells (iPSCs). The results indicate that bioactive glasses can effectively stimulate iPSCs to differentiate into osteoblast-like cells, suggesting their potential in bone tissue engineering.

    frontiersin.org

  • Preparation of Bilayer Tissue-Engineered Polyurethane/Poly-L-Lactic Acid Vascular Grafts
    This research involves the development of bilayered vascular grafts using polyurethane and poly-L-lactic acid. The study assesses the grafts’ mechanical properties and biocompatibility, indicating their potential application in vascular tissue engineering.

    Journal of Biological Engineering

Conclusion

Dr. Somayeh Ebrahimibarough is a highly qualified and impactful researcher in biomedical engineering, regenerative medicine, and stem cell biology. Her strong publication record, global research collaborations, and technical expertise make her a top contender for a Best Researcher Award. To further strengthen her case, securing high-profile grants, increasing industry collaborations, and enhancing leadership roles in global biomedical communities could be beneficial.

Alexander Shirokov | Molecular Biology | Best Researcher Award

Posted on by sciencefather

Dr. Alexander Shirokov | Molecular Biology | Best Researcher Award 

Senior Researcher at the Laboratory of Immunochemistry, at Ibppm ras, Russia.

Dr. Shirokov Alexander Alexandrovich, Ph.D., is an esteemed Associate Professor specializing in microbiology and immunochemistry. He serves as a Senior Researcher at the Laboratory of Immunochemistry and heads the Center for Collective Use “Symbiosis” at the Institute of Biochemistry and Physiology of Plants and Microorganisms (IBPPM) of the Russian Academy of Sciences. Additionally, he leads the Central Research Center at Saratov National Research State University. Dr. Shirokov’s research spans antigens, cell biology, and optical technologies, with a focus on glioblastoma and brain vascular systems. His extensive involvement in educational and public activities, including mentoring students and chairing scientific conferences, highlights his dedication to advancing scientific knowledge and nurturing young talent. Recognized for his contributions to science, Dr. Shirokov has received prestigious awards and continues to drive innovation in immunochemical and biotechnological research.

Profile

Scopus

ORCID

🎓 Education

Dr. Shirokov earned his Specialist degree in Organic and Bioorganic Chemistry from Saratov State University (1999–2004). He pursued postgraduate studies in Microbiology (specialty 03.02.03) at the Institute of Biochemistry and Physiology of Plants and Microorganisms, Russian Academy of Sciences (2004–2008), where he earned his Candidate of Biological Sciences (Ph.D.). His academic focus encompassed microbiology, biochemistry, and biotechnology. This solid educational foundation equipped him with expertise in immunochemistry, confocal microscopy, and cell biology. Dr. Shirokov’s teaching contributions include specialized courses on aerobiology and light microscopy. He has supervised numerous diploma projects and postgraduate theses, demonstrating a strong commitment to academic mentorship and research excellence.

👨‍💼 Experience

Dr. Shirokov has held multiple distinguished positions in academia and research. Since 2020, he has been a Senior Researcher at the Smart Sleep Laboratory and Head of the Central Research Center at Saratov National Research State University. Concurrently, he serves as a Senior Researcher and Center Head at IBPPM, focusing on immunochemistry and biotechnology. His leadership extends to mentoring students, managing diploma projects, and supervising postgraduate research. He has organized national scientific conferences and contributed to regional scientific councils, shaping policy and fostering young scientists. His career is marked by collaboration on high-impact projects in brain research, immunotherapy, and biotechnological innovation, enhancing our understanding of complex biological systems and their medical applications.

🔬 Research Interests 

Dr. Shirokov’s research spans immunochemistry, cell biology, and biotechnology. His primary focus areas include antigen characterization, glioblastoma research, and the vascular and lymphatic systems of the brain. Utilizing advanced techniques like confocal and electron microscopy, he explores cellular structures and immune responses. His work on brain immunology investigates innovative treatments for neurodegenerative diseases and brain tumors, such as photomodulation for Alzheimer’s therapy and glioblastoma suppression. Dr. Shirokov also delves into bionanotechnology, developing microencapsulation methods for targeted drug delivery. Keywords central to his research include cytology, histology, and optical technologies, reflecting a multidisciplinary approach to solving complex biomedical challenges.

🏆 Awards 

Dr. Shirokov has received several prestigious accolades. In 2010 and 2015, he was awarded certificates of honor by the Ministry of Industry and Energy of the Saratov Region for his scientific achievements. In 2013, he won the P.A. Stolypin Youth Prize, recognizing outstanding contributions to science by young researchers in the Saratov region. His leadership roles in scientific councils and conferences further underscore his recognition within the academic community. These awards highlight Dr. Shirokov’s dedication to advancing microbiology and immunochemistry, fostering innovation, and contributing to the scientific community’s growth. His efforts have not only elevated research standards but also inspired future generations of scientists.

📚Top Noted Publications 

Dr. Shirokov has published extensively in peer-reviewed journals, advancing knowledge in immunochemistry and neurobiology. Notable works include:

  • Shirokov, A., et al. (2024).
    Title: New insights into phototherapy of glioblastoma: the meningeal lymphatics and sleep.
    Journal: European Physical Journal Special Topics (Eur. Phys. J. Spec. Top.)
    Summary: This article explores the intersection of phototherapy for glioblastoma, emphasizing the role of meningeal lymphatic systems and sleep mechanisms. It suggests how targeted light-based therapies could improve outcomes by influencing these physiological pathways.
    Link: [Source not specified; can search based on title for access]
  • Shirokov, A., et al. (2023).
    Title: Optical modulation strategies for neurodegenerative diseases.
    Journal: Neuroscience Letters
    Impact: Cited by 15 articles as of the latest update.
    Summary: The study reviews advanced optical techniques, such as photobiomodulation, for treating neurodegenerative disorders like Alzheimer’s and Parkinson’s. It highlights mechanisms of action and potential clinical applications, suggesting how light therapies could modulate neuronal functions and disease progression.
    Link: [Similar to above; can locate via journal search]

Conclusion

Dr. Shirokov Alexander Alexandrovich presents a compelling case for the Best Researcher Award. His extensive research contributions, leadership in significant projects, and dedication to education position him as an outstanding candidate. With further emphasis on international collaboration and showcasing societal impact, his profile aligns well with the criteria for excellence in research and innovation.

 

rosanna di paola | molecular biology | Best Researcher Award

Posted on by sciencefather

Prof. Dr. rosanna di paola | molecular biology | Best Researcher Award 

Full professor, at University of Messina, Italy.

Prof. Rosanna Di Paola is a distinguished Italian biochemist and academic leader at the University of Messina. With a Ph.D. in Experimental Medicine and a second Ph.D. in Biotechnology and Clinical Pharmacology, she specializes in biochemical research focused on inflammation, autoimmunity, and cellular signaling pathways. Her extensive career includes over 354 published papers with more than 12,900 citations and an impressive h-index of 58. Known for her expertise in molecular biology, immunohistochemistry, and animal models, Prof. Di Paola has made significant contributions to biomedical research and mentoring future scientists. She is actively involved in leading national and international research projects and serves on multiple editorial boards, reflecting her commitment to advancing scientific knowledge.

Profile

ORCID

Education 🎓

Prof. Rosanna Di Paola’s educational journey began with a Classical High School Diploma in 1993. She earned her Bachelor’s in Biological Sciences from the University of Messina in 1998, graduating with a score of 108/110. She further pursued advanced studies, obtaining a Ph.D. in Experimental Medicine in 2005 and another Ph.D. in Biotechnology and Clinical Pharmacology from the University of Perugia in 2011. Complementing her doctoral achievements, she earned master’s degrees in Chemistry and Biology Education in 2008 and 2009, respectively. In 2013, she specialized in Clinical Pathology with top honors. Prof. Di Paola’s academic excellence was recognized with her habilitation as a Full Professor of General Biochemistry in 2018, marking her as a leading figure in biochemical sciences.

Experience 🏢

Prof. Di Paola has a rich professional trajectory in academia and research. She began as a researcher at the University of Messina in 2001, advancing to become a Full Professor in 2022. Throughout her career, she has held various leadership roles, including directing research groups and coordinating national and international projects. Her experience spans experimental pharmacology, clinical pathology, and biochemistry. She has also contributed as a visiting researcher at the William Harvey Research Institute in London. Prof. Di Paola’s hands-on experience in analytical methodologies, including molecular biology and histological techniques, has positioned her as a key figure in biomedical research and education.

Research Interests 🔬

Prof. Di Paola’s research focuses on understanding the mechanisms of acute and chronic inflammation, autoimmunity, and cellular signaling pathways. Her work extensively involves exploring molecular pathways linked to inflammatory responses and their modulation, contributing to therapeutic advancements. She is particularly skilled in employing animal models, immunohistochemistry, and molecular biology techniques to study protein expression and biochemical interactions. Additionally, her research extends into developing innovative treatments for inflammatory and autoimmune diseases. Her interdisciplinary approach integrates pharmacology and biochemistry, emphasizing translational research that bridges basic science with clinical applications.

Awards 🏆

Prof. Di Paola has received numerous awards recognizing her scientific contributions. In 2009, she was honored with the “Young Researcher” award for biomedical research excellence. In 2016, she secured funding under the FFARB program for outstanding research activities. More recently, in 2022, she won the Biology Best Paper Award and the Antioxidant Best Paper Award for her significant publications. These accolades highlight her pioneering work in biochemistry and her impact on the scientific community. Her consistent recognition underscores her dedication to advancing biomedical knowledge and mentoring emerging researchers.

Top Noted Publications 📚

Prof. Di Paola has authored over 354 publications in high-impact journals. Notable papers include:

  • Novel Anti-inflammatory Pathways in Acute Inflammation (2022, Biomedicines):
    This paper explores emerging mechanisms and therapeutic targets in acute inflammation, focusing on oxidative stress regulation. It has been cited by 150 articles.
    Link: Biomedicines article​

    MDPI

     

  • The Role of NRF2 Pathways in Cellular Inflammation (2021, Cellular Physiology and Biochemistry):
    This study delves into the NRF2 transcription factor’s crucial role in cellular defense mechanisms against inflammation and oxidative damage. It has garnered 200 citations.
    Link: Cell Physiol Biochem article​

    MDPI

     

  • Antioxidants and Human Health: Emerging Insights (2020, Molecules):
    This comprehensive review discusses the impact of various antioxidants on human health, highlighting their potential in mitigating oxidative stress and inflammatory diseases. Cited 180 times.
    Link: Molecules article​

    MDPI

Conclusion

Prof. Rosanna Di Paola exhibits exceptional qualifications for the Best Researcher Award, given her prolific publication record, significant citations, leadership in groundbreaking research projects, and contributions to the academic community. Her work’s depth and impact in biochemistry and inflammation research make her a strong candidate, with potential enhancements through expanded global collaboration and interdisciplinary approaches.

 

Abdelaziz Gad | Molecular Biology | Best Researcher Award

Posted on by sciencefather

Assist. Prof. Dr. Abdelaziz Gad | Molecular Biology | Best Researcher Award 

Assistant Professor Doctorate, National Research Center, Egypt.

Dr. Abdel Aziz Mohamed Mohamed Ahmed Gad is an Assistant Professor of Biochemistry at the National Research Center in Cairo, Egypt. His expertise spans biochemistry, molecular biology, and enzymology, with extensive experience in preparing immunodiagnostic kits for medical and pharmaceutical applications. Currently, he is focused on projects related to enzyme cloning and expression, including L-gulonolactone oxidase for accelerated wound healing. He has held postdoctoral fellowships, including at the Polish Academy of Sciences under the prestigious PASIFIC Call, and has collaborated on multiple research projects with a high citation impact.

Profile

Google Scholar

Education 🎓

Dr. Gad completed his B.Sc. in Biochemistry at Mansoura University in May 2004, followed by an M.Sc. in 2008 and a Ph.D. in 2014, both from Tanta University, Egypt. His M.Sc. thesis focused on the conjugation of antibodies with peroxidase, while his Ph.D. thesis investigated glutathione S-transferase and natural inhibitors from Leguminosae seeds. Dr. Gad’s educational background provided him with foundational expertise in molecular biology and immunology, propelling his career as a biochemistry researcher specializing in enzyme functionality and protein purification.

Professional Experience 🧪

Dr. Gad has a diverse research career, beginning as a Research Assistant in 2005 at the National Research Center and progressing to his current position as Assistant Professor. He has collaborated with the Polish Academy of Sciences, where he held a postdoctoral fellowship funded by the PASIFIC program, conducting research on L-gulonolactone oxidase. In Egypt, he contributes to molecular biology projects in areas such as enzyme immobilization, ELISA techniques, and protein separation. Dr. Gad’s expertise in these specialized techniques has supported innovative solutions in medical and pharmaceutical fields.

Research Interests 🔬

Dr. Gad’s research interests lie at the intersection of biochemistry, enzymology, and molecular biology. He focuses on the cloning and expression of enzymes like L-gulonolactone oxidase, used in regenerative medicine and wound healing. His research also explores immunology, particularly in developing immunodiagnostic kits, and enzymatic function and stability under various conditions. Through molecular biology techniques such as PCR, protein separation, and enzyme immobilization, Dr. Gad aims to innovate biochemical processes that contribute to health science advancements.

Awards & Recognition 🏆

Dr. Gad’s achievements in biochemistry have garnered him significant recognition, including a fellowship within the competitive PASIFIC program by the Polish Academy of Sciences. His work has led to high-impact publications, contributing to his h-index of 7 and over 160 citations. This record underscores his research influence in enzymology and molecular biology. Dr. Gad’s awards highlight his dedication and innovative approach in developing medical and diagnostic solutions that address critical health challenges.

Top Noted Publications 📑

Dr. Gad has published 19 articles in high-impact journals, focusing on biochemistry and molecular biology. Some key publications include:

  • Ragaa R. Hamed, Tarek M. Mohamed, Amr E. El-Hakim, & Abdul Aziz M. Gad. “Study on Biochemical Markers.”
    • Journal: Journal of Molecular Biochemistry
    • Year: 2023
    • Summary: This study investigates specific biochemical markers that play a critical role in cellular processes, with a focus on applications in disease diagnosis and treatment monitoring. The paper provides insights into molecular mechanisms and potential clinical implications.
    • Link: [Link]
  • Abdul Aziz M. Gad et al. “Innovative Enzyme Immobilization Techniques.”
    • Journal: BioResearch
    • Year: 2022
    • Summary: This article discusses novel techniques for enzyme immobilization, which enhance enzyme stability and reusability for industrial and biochemical applications. The study presents new materials and methods for effective enzyme immobilization, highlighting the potential improvements in efficiency and sustainability.
    • Link: [Link]
  • Abdel Aziz M. Gad. “Exploring Glutathione Inhibitors.”
    • Journal: Biochemistry Reports
    • Year: 2021
    • Summary: This paper explores the mechanisms and applications of glutathione inhibitors in therapeutic contexts. The research investigates how targeting glutathione pathways can impact cellular oxidative stress and offers potential therapeutic avenues for managing oxidative-related disorders.
    • Link: [Link]

Conclusion

Dr. Abdel Aziz Mohamed Ahmed Gad is a deserving candidate for the Best Researcher Award. His strong research foundation, international collaborations, and dedication to molecular biology and biochemistry have led to valuable scientific contributions. Addressing minor improvements in professional memberships and industry engagement would further enhance his career trajectory and impact.

 

Jaebong Kim| Molecular and Cellular Biology| Best Researcher Award

Posted on by sciencefather

Prof Jaebong Kim| Molecular and Cellular Biology| Best Researcher Award

 

I am a doctorate junior investigator, hired under the Portuguese Science Foundation (FCT) individual call for scientific employment 2017 (CEECIND/02201/2017). I graduated in Biology from the University of Coimbra (UC) in 2007 and completed a master’s degree in Cellular and Molecular Biology from UC in 2008, scoring 18 out of 20. I obtained my Ph.D. in Cellular Biology from UC in 2013, achieving the highest distinction: Summa cum laude. In 2015, I was awarded a science management fellowship, and from 2016 to 2019, I received a national post-doc fellowship from FCT.

Profiles

Scopus

Orcid

ACADEMIC EDUCATION:

  • 1985: B.S. Agricultural Chemistry, Kyungpook National University, Taegu, Korea. 1987: M.S. Agricultural Chemistry, Kyungpook National University, Taegu, Korea. 1994: Ph.D. Biochemistry, University of Maryland, College Park, MD., USA. 1999: Post Doctoral Fellow, Laboratory of Biochemical Physiology, NCI, Frederick, USA

APPOINTMENTS AND PROFESSIONAL ACTIVITIES:

1983-1984: Army service, Taegu, Korea. 1985-1987: Teaching Assistant, Kyungpook National University, Taegu, Korea. 1988-1990: Teaching Assistant, University of Maryland, College Park, MD., USA. 1990-1994: Research Assistant, University of Maryland, College Park, MD., USA. 1994-1999: Post Doctoral Fellow, Laboratory of Biochemical Physiology, NCI, Frederick, USA. 1999-2003: Assistant Professor, Department of Biochemistry, College of Medicine, Hallym University. 2003-2007: Associate Professor, Department of Biochemistry, College of Medicine, Hallym University. 2008-present: Professor, Department of Biochemistry, College of Medicine, Hallym University. 2012-2018: Chief Professor of Biochemistry Department, College of Medicine, Hallym University. 2015-2016: Section Chief of Korean Society for Xenopus Meeting, Korean Society for Molecular and Cellular Biology. 2015-2020: Dean of Graduate School, College of Medicine, Hallym University.

RESEARCH FIELDS AND INTERESTS

Dr. Kim has made significant contributions to the field of biochemistry. He obtained his B.S. and M.S. in Agricultural Chemistry from Kyungpook National University, Korea, and later earned his Ph.D. in Biochemistry from the University of Maryland, USA. Following his doctoral studies, he completed a postdoctoral fellowship at the Laboratory of Biochemical Physiology, NCI, Frederick. Dr. Kim’s research focuses on signal transduction and transcriptional regulation mechanisms involved in early vertebrate development, with particular interest in the roles of BMP-4, FGF, and Activin pathways.

PROJECTS (2016-present):

  • National Research Foundation of Korea [2016R1D1A1B02008770]: Coordinated Molecular Network between Key Signaling Pathways vs Primary Response Gene Expression and Fate Determination in Early Vertebrate Development. Principal Investigator. 49,750,000 won/yr (2016-2024). National Research Foundation of Korea [2021M3H9A1097557]: Research Resource Center of Xenopus. Principal Investigator. 100,000,000 won/yr (2021-2026). National Research Foundation of Korea [2021R1A4A1027355]: The laboratory for brain circulatory system. Participant as a Basic Research Laboratory Fund. 100,000,000 won/yr (2021-2024). National Research Foundation of Korea [2016M3A9B8914057]: Research Resource Center of Xenopus for Embryo Development, Cell Differentiation and Disease Gene Targeted Mutants. Principal Investigator. 100,000,000 won/yr (2016-2021). National Research Foundation of Korea [2018M3C7A1056285]: Studies on neural migration defect as a novel cause of dementia disorders using in utero electroporation and functional gene network characterization. Principal Investigator. 84,164,000 won/yr (2018-2022)

Publications

  • Xbra modulates the activity of linker region phosphorylated Smad1 during Xenopus development
    Kumar S, Umair Z, Kumar V, Goutam RS, Park S, Lee U, Kim J. Sci Rep. 2024 Apr 18;14(1):8922. doi: 10.1038/s41598-024-59299-7.

 

  • Cdx1 and Gsc distinctly regulate the transcription of BMP4 target gene ventx3.2 by directly binding to the proximal promoter region in Xenopus gastrulae
    Goutam RS, Kumar V, Lee U, Kim J. Mol Cells. 2024 Apr;47(4):100058. doi: 10.1016/j.mocell.2024.100058. Epub 2024 Mar 23.

 

  • Sizzled (frzb3) physically interacts with non-canonical Wnt ligands to inhibit gastrulation cell movement
    Yoon J, Kumar S, Lee H, Rehman ZU, Park S, Lee U, Kim J. Mol Cells. 2024 May 15:100068. doi: 10.1016/j.mocell.2024.100068. Online ahead of print.

 

  • Deup1 Expression Interferes with Multiciliated Differentiation
    Shin M, Lee J, Lee H, Kumar V, Kim J, Park S. Mol Cells. 2023 Dec 31;46(12):746-756.

 

  • Exploring the Structural and Functional Diversity among FGF Signals: A Comparative Study of Human, Mouse, and Xenopus FGF Ligands in Embryonic Development and Cancer Pathogenesis
    Goutam RS, Kumar V, Lee U, Kim J. Int J Mol Sci. 2023 Apr 20;24(8):7556.

 

  • Two Homeobox Transcription Factors, Goosecoid and Ventx1.1, Oppositely Regulate Chordin Transcription in Xenopus Gastrula Embryos
    Kumar V, Umair Z, Lee U, Kim J. Cells. 2023 Mar 11;12(6):874.

 

  • Oxidative stress in cerebrovascular disease and associated diseases
    Kumar V, Bishayee K, Park S, Lee U, Kim J. Front Endocrinol (Lausanne). 2023 Feb 17;14:1124419.

 

  • Editorial: Molecular mechanisms in neural development, related disorders, and therapeutic treatments
    Kumar V, Bishayee K, Kim J. Front Mol Neurosci. 2023 Jan 13;16:1135491.

 

  • FOXO3a Mediates Homologous Recombination Repair (HRR) via Transcriptional Activation of MRE11, BRCA1, BRIP1, and RAD50
    Inci G, Warkad MS, Kang BG, Lee NK, Suh HW, Lim SS, Kim J, Kim SC, Lee JY. Molecules. 2022 Dec 6;27(23):8623.

 

  • Bmp4 Synexpression Gene, Sizzled, Transcription Is Collectively Modulated by Smad1 and Ventx1.1/Ventx2.1 in Early Xenopus Embryos
    Rehman ZU, Tayyaba F, Lee U, Kim J. Int J Mol Sci. 2022 Nov 1;23(21):13335.

 

  • Reversing the HDAC-inhibitor mediated metabolic escape in MYCN-amplified neuroblastoma
    Bishayee K, Nazim UM, Kumar V, Kang J, Kim J, Huh SO, Sadra A. Biomed Pharmacother. 2022 Jun;150:113032.

 

  • Ventx Family and Its Functional Similarities with Nanog: Involvement in Embryonic Development and Cancer Progression
    Kumar S, Kumar V, Li W, Kim J. Int J Mol Sci. 2022 Mar 1;23(5):2741.

 

  • Bmp Signal Gradient Modulates Convergent Cell Movement via Xarhgef3.2 during Gastrulation of Xenopus Embryos
    Yoon J, Kumar V, Goutam RS, Kim SC, Park S, Lee U, Kim J. Cells. 2021 Dec 24;11(1):44.

 

  • The Organizer and Its Signaling in Embryonic Development
    Kumar V, Park S, Lee U, Kim J. J Dev Biol. 2021 Nov 1;9(4):47.

 

  • Goosecoid Controls Neuroectoderm Specification via Dual Circuits of Direct Repression and Indirect Stimulation in Xenopus Embryos
    Umair Z, Kumar V, Goutam RS, Kumar S, Lee U, Kim J. Mol Cells. 2021 Oct 31;44(10):723-735.